Australia markets closed

Firebrick Pharma Limited (FRE.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0620-0.0030 (-4.62%)
At close: 03:49PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 11.12M
Enterprise value 9.81M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.00
Price/book (mrq)6.99
Enterprise value/revenue 5.47
Enterprise value/EBITDA -2.13

Trading information

Stock price history

Beta (5Y monthly) 1.82
52-week change 3-69.00%
S&P500 52-week change 321.08%
52-week high 30.3600
52-week low 30.0360
50-day moving average 30.0548
200-day moving average 30.0911

Share statistics

Avg vol (3-month) 3280.08k
Avg vol (10-day) 31.16M
Shares outstanding 5179.31M
Implied shares outstanding 6187.6M
Float 889.65M
% held by insiders 150.38%
% held by institutions 10.66%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -251.57%
Operating margin (ttm)-48.02%

Management effectiveness

Return on assets (ttm)-74.49%
Return on equity (ttm)-136.04%

Income statement

Revenue (ttm)1.82M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)7,953.80%
Gross profit (ttm)N/A
EBITDA -4.5M
Net income avi to common (ttm)-4.57M
Diluted EPS (ttm)-0.0300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.31M
Total cash per share (mrq)0.01
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)5.17
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-4.6M
Levered free cash flow (ttm)-3.14M